Literature DB >> 28586292

A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.

Devin M Stranford1,2, Michelle E Hung3, Emma S Gargus4,5, Ramille N Shah5,6,7,8, Joshua N Leonard1,2,9,10.   

Abstract

Extracellular vesicles (EVs) are nanometer-scale particles that are secreted by cells and mediate intercellular communication by transferring biomolecules between cells. Harnessing this mechanism for therapeutic biomolecule delivery represents a promising frontier for regenerative medicine and other clinical applications. One challenge to realizing this goal is that to date, our understanding of which factors affect EV uptake by recipient cells remains incomplete. In this study, we systematically investigated such delivery questions in the context of breast cancer cells, which are one of the most well-studied cell types with respect to EV delivery and therefore comprise a facile model system for this investigation. By displaying various targeting peptides on the EV surface, we observed that although displaying GE11 on EVs modestly increased uptake by MCF-7 cells, neuropeptide Y (NPY) display had no effect on uptake by the same cells. In contrast, neurotensin (NTS) and urokinase plasminogen activator (uPA) display reduced EV uptake by MDA-MB-231 cells. Interestingly, EV uptake rate did not depend on the source of the EVs; breast cancer cells demonstrated no increase in uptake on administration of breast cancer-derived EVs in comparison to HEK293FT-derived EVs. Moreover, EV uptake was greatly enhanced by delivery in the presence of polybrene and spinoculation, suggesting that maximal EV uptake rates are much greater than those observed under basal conditions in cell culture. By investigating how the cell's environment might provide cues that impact EV uptake, we also observed that culturing cells on soft matrices significantly enhanced EV uptake, compared to culturing on stiff tissue culture polystyrene. Each of these observations provides insights into the factors impacting EV uptake by breast cancer cells, while also providing a basis of comparison for systematically evaluating and perhaps enhancing EV uptake by various cell types.

Entities:  

Keywords:  EVs; breast cancer; exosomes; extracellular vesicles

Mesh:

Substances:

Year:  2017        PMID: 28586292      PMCID: PMC5689128          DOI: 10.1089/ten.TEA.2017.0158

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  36 in total

1.  Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells.

Authors:  Bas W M van Balkom; Olivier G de Jong; Michiel Smits; Jolanda Brummelman; Krista den Ouden; Petra M de Bree; Monique A J van Eijndhoven; D Michiel Pegtel; Willem Stoorvogel; Thomas Würdinger; Marianne C Verhaar
Journal:  Blood       Date:  2013-03-26       Impact factor: 22.113

Review 2.  Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine.

Authors:  Tek N Lamichhane; Sonja Sokic; John S Schardt; Rahul S Raiker; Jennifer W Lin; Steven M Jay
Journal:  Tissue Eng Part B Rev       Date:  2014-07-24       Impact factor: 6.389

Review 3.  Therapeutic applications of extracellular vesicles: clinical promise and open questions.

Authors:  Bence György; Michelle E Hung; Xandra O Breakefield; Joshua N Leonard
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

4.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

5.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.

Authors:  Yanhua Tian; Suping Li; Jian Song; Tianjiao Ji; Motao Zhu; Gregory J Anderson; Jingyan Wei; Guangjun Nie
Journal:  Biomaterials       Date:  2013-12-15       Impact factor: 12.479

6.  Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Authors:  Lily Yang; Xiang-Hong Peng; Y Andrew Wang; Xiaoxia Wang; Zehong Cao; Chunchun Ni; Prasanthi Karna; Xinjian Zhang; William C Wood; Xiaohu Gao; Shuming Nie; Hui Mao
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

7.  uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Authors:  Lily Yang; Hari Krishna Sajja; Zehong Cao; Weiping Qian; Laura Bender; Adam I Marcus; Malgorzata Lipowska; William C Wood; Y Andrew Wang
Journal:  Theranostics       Date:  2013-12-17       Impact factor: 11.556

Review 8.  Extracellular vesicles: potential roles in regenerative medicine.

Authors:  Olivier G De Jong; Bas W M Van Balkom; Raymond M Schiffelers; Carlijn V C Bouten; Marianne C Verhaar
Journal:  Front Immunol       Date:  2014-12-03       Impact factor: 7.561

9.  pHuji, a pH-sensitive red fluorescent protein for imaging of exo- and endocytosis.

Authors:  Yi Shen; Morgane Rosendale; Robert E Campbell; David Perrais
Journal:  J Cell Biol       Date:  2014-11-10       Impact factor: 10.539

10.  Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth.

Authors:  Arda Mizrak; Mehmet Fatih Bolukbasi; Gokhan Baris Ozdener; Gary J Brenner; Sibylle Madlener; Erdogan Pekcan Erkan; Thomas Ströbel; Xandra O Breakefield; Okay Saydam
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

View more
  8 in total

Review 1.  Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment.

Authors:  Divya B Patel; Marco Santoro; Louis J Born; John P Fisher; Steven M Jay
Journal:  Biotechnol Adv       Date:  2018-09-12       Impact factor: 14.227

2.  Matrix stiffness regulates microvesicle-induced fibroblast activation.

Authors:  Samantha C Schwager; Francois Bordeleau; Jian Zhang; Marc A Antonyak; Richard A Cerione; Cynthia A Reinhart-King
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-24       Impact factor: 4.249

3.  Elucidating Design Principles for Engineering Cell-Derived Vesicles to Inhibit SARS-CoV-2 Infection.

Authors:  Taylor F Gunnels; Devin M Stranford; Roxana E Mitrut; Neha P Kamat; Joshua N Leonard
Journal:  Small       Date:  2022-04-07       Impact factor: 15.153

4.  Immortalizing Mesenchymal Stromal Cells from Aged Donors While Keeping Their Essential Features.

Authors:  María Piñeiro-Ramil; Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; Silvia Rodríguez-Fernández; Tamara Hermida-Gómez; Francisco J Blanco-García; Isaac Fuentes-Boquete; Silvia Díaz-Prado
Journal:  Stem Cells Int       Date:  2020-06-16       Impact factor: 5.443

5.  Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection.

Authors:  Taylor F Gunnels; Devin M Stranford; Roxana E Mitrut; Neha P Kamat; Joshua N Leonard
Journal:  bioRxiv       Date:  2021-12-10

6.  A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.

Authors:  Carmen Campos-Silva; Yaiza Cáceres-Martell; Estela Sánchez-Herrero; Amaia Sandúa; Alexandra Beneitez-Martínez; Álvaro González; Mariano Provencio; Atocha Romero; Ricardo Jara-Acevedo; María Yáñez-Mó; Mar Valés-Gómez
Journal:  J Nanobiotechnology       Date:  2022-02-08       Impact factor: 10.435

7.  Extracellular Vesicles Mediate the Intercellular Exchange of Nanoparticles.

Authors:  Xian Wu; Tang Tang; Yushuang Wei; Katherine A Cummins; David K Wood; Hong-Bo Pang
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

8.  Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis.

Authors:  Luqian Li; Fei Xiao; Guolian Liu; Yufeng Chen
Journal:  Dis Markers       Date:  2022-02-10       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.